Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

FEMY

FEMY News

Newswire

10:45

Femasys shares surge 11.51% intraday after PharmaCyte Biotech liquidates equity stake, boosting cash and securities to $20M.

09:17

PharmaCyte Biotech Strengthens Financial Position with Femasys Monetization

10:31

Femasys shares surge 11.87% intraday after Laidlaw initiates Buy rating with $6.50 target.

09:52

Femasys Receives Buy Rating from Laidlaw & Co. with $6.5 PT

06:36

Femasys shares surge 16.05% premarket after Laidlaw initiates Buy rating with $6.50 target, citing FemaSeed’s superior pregnancy rates and expanded market strategy.

View More

About FEMY

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More